The arznei-telegramm® (a-t) is now in its 54th year to inform medical professionals about the benefits and risks of drugs - neutrally and independently, without advertising and financed exclusively by subscriptions. It is published monthly and provides up-to-date practical recommendations with a special focus on safety and benefits relevant to patients.
The atd drug database (additional license required) evaluates more than 2,000 active ingredients and thus around 18,000 drugs in detail. It lists their prices, indications, contraindications, side effects, interactions and pharmacokinetics and links to over 16,000 additional sources. The drug database is updated and supplemented monthly, for example with new drugs.
Non-subscribers can view all issues of the arznei-telegramm® except for the years since 2015, from which selected articles are freely accessible.
As a subscriber, you have full access (except for print subscriptions without online access).
• to all arznei-telegramm® texts from 1990 to the current edition
• to the e a-t (additional texts online)
• to the blitz-a-t (sent by e-mail) for important "in between"
• to the NETWORK UAW database.
The atd drug database (additional license required) evaluates more than 2,000 active ingredients and thus around 18,000 drugs in detail. It lists their prices, indications, contraindications, side effects, interactions and pharmacokinetics and links to over 16,000 additional sources. The drug database is updated and supplemented monthly, for example with new drugs.
Non-subscribers can view all issues of the arznei-telegramm® except for the years since 2015, from which selected articles are freely accessible.
As a subscriber, you have full access (except for print subscriptions without online access).
• to all arznei-telegramm® texts from 1990 to the current edition
• to the e a-t (additional texts online)
• to the blitz-a-t (sent by e-mail) for important "in between"
• to the NETWORK UAW database.
Show More
